Shengyong Yang
ORCID: 0000-0001-5147-3746Also affiliated with Sichuan University, State Key Laboratory of Biotherapy
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo”.
Jingxin Qiao, Chaemin Yoon, Guo Zhang, Yuxin Hou, Xiaoyan Xia +32 more
Yoshinobu Odaka, Zhu Huang, Bing Cheng, Wang Liu, Lin Li +9 more
Jyoti Vishwakarma, Katharina Sylvester, Nobuyo Higashi‐Kuwata, Agnieszka Dąbrowska, Renee Delgado +16 more